Dantari
San Diego, United States· Est.
Dantari develops targeted antibody-drug conjugates using its proprietary platform to deliver therapies for cancer and other diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $47M
About
Dantari develops targeted antibody-drug conjugates using its proprietary platform to deliver therapies for cancer and other diseases.
OncologyAntibodiesDrug Delivery
Funding History
1Total raised:$47M
PIPE$47M